Publication: Unintended HIV-1 Infection During Analytical Therapy Interruption
| dc.contributor.author | Ugarte, Ainoa | |
| dc.contributor.author | Romero, Yolanda | |
| dc.contributor.author | Tricas, Amparo | |
| dc.contributor.author | Casado, Concepcion | |
| dc.contributor.author | Lopez-Galindez, Luis Cecilio | |
| dc.contributor.author | García, Felipe | |
| dc.contributor.author | Leal, Lorna | |
| dc.contributor.funder | Ministerio de Economía (España) | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
| dc.contributor.funder | RETICS-Sida (RIS-ISCIII) (España) | |
| dc.contributor.funder | Government of Catalonia (España) | |
| dc.date.accessioned | 2025-01-15T10:55:07Z | |
| dc.date.available | 2025-01-15T10:55:07Z | |
| dc.date.issued | 2020-04-27 | |
| dc.description.peerreviewed | Sí | |
| dc.description.sponsorship | This work was partially supported by the following grants: the Spanish Ministry of Economy (MINECO) (grants: SAF2015-66193-R, RTI2018-096309-B-I00), the Fondo de Investigación Sanitaria (FIS) PI15/00480, the Fondo Europeo para el Desarrollo Regional (FEDER), the SPANISH AIDS Research Network RD16/0025/0002–ISCIII–FEDER (RIS), and the CERCA Programme/Generalitat de Catalunya SGR 615 and SGR 653. F.G. has received support from José María Segovia de Arana contracts. Work in C. L.-G.’s laboratory was supported by grants SAF (2010–17226) and (2016-77894-R) from MINECO (Spain) and FIS (PI 13/02269, ISCIII) and in part by the RIS-RETIC grants RD06/006/0036 and RD12/0017/0028 funded by the ISC III-FEDER. | |
| dc.format.number | 10 | |
| dc.format.page | 1740-1742 | |
| dc.format.volume | 221 | |
| dc.identifier.citation | Ugarte A, Romero Y, Tricas A, Casado C, Lopez-Galindez C, Garcia F, Leal L. Unintended HIV-1 Infection During Analytical Therapy Interruption. J Infect Dis. 2020 Apr 27;221(10):1740-1742. | |
| dc.identifier.doi | 10.1093/infdis/jiz611 | |
| dc.identifier.e-issn | 1537-6613 | |
| dc.identifier.issn | 0022-1899 | |
| dc.identifier.journal | The Journal of infectious diseases | |
| dc.identifier.pubmedID | 31742347 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/26023 | |
| dc.language.iso | eng | |
| dc.publisher | Oxford University Press | |
| dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//SAF2015-66193-R/ES/UTILIZACION DE MEDICINA DE SISTEMAS PARA LA PREDICCION DE LA INMUNOGENICIDAD Y EFICACIA DE VACUNAS TERAPEUTICAS FRENTE A VIH/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-096309-B-I00/ES/DESARROLLO PRECLINICO DE UNA INNOVADORA VACUNA ARNM CONTRA EL VIH/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PI15%2F00480/ES/DESARROLLO DE UNA VACUNA TERAPÉUTICA FRENTE AL VIH BASADA EN UNA NUEVA FORMULACIÓN DE mRNA CON NANOPARTÍCULAS/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//RD16%2F0025%2F0002/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN SIDA (RIS)/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI13/02269 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD06/006/0036 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD12/0017/0028 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2010–17226-R | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2016-77894-R | |
| dc.relation.publisherversion | https://doi.org/10.1093/infdis/jiz611 | |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología (CNM) | |
| dc.repisalud.institucion | ISCIII | |
| dc.repisalud.institute | IIS::IDIBAPS - Instituto de Investigaciones Biomédicas August Pi i Sunyer (Cataluña) | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject.mesh | AIDS Vaccines | |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Anti-HIV Agents | |
| dc.subject.mesh | Anti-HIV Agents | |
| dc.subject.mesh | Drug Contamination | |
| dc.subject.mesh | HIV Infections | |
| dc.subject.mesh | HIV Infections | |
| dc.subject.mesh | HIV-1 | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Phylogeny | |
| dc.subject.mesh | Sexual Partners | |
| dc.title | Unintended HIV-1 Infection During Analytical Therapy Interruption | |
| dc.type | letter to the editor | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 7e48a263-54c3-4de0-81e7-f7446c918f2d | |
| relation.isAuthorOfPublication | f57c2687-907b-44ea-a780-7920ff8b9b41 | |
| relation.isAuthorOfPublication | 7e48a263-54c3-4de0-81e7-f7446c918f2d | |
| relation.isAuthorOfPublication.latestForDiscovery | 7e48a263-54c3-4de0-81e7-f7446c918f2d | |
| relation.isFunderOfPublication | ca7182dc-aaab-45ec-a09d-755563fe05f2 | |
| relation.isFunderOfPublication | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isFunderOfPublication | efa64f05-b985-4984-8f1e-5fc4ef21f502 | |
| relation.isFunderOfPublication | cf779d8b-1517-4249-81b7-65344ce5172d | |
| relation.isFunderOfPublication | c6fbffec-abb4-4f0e-81e0-3b254d5dd85d | |
| relation.isFunderOfPublication.latestForDiscovery | ca7182dc-aaab-45ec-a09d-755563fe05f2 | |
| relation.isPublisherOfPublication | 465a0b1e-d9df-4342-b738-86ffcafc4bcf | |
| relation.isPublisherOfPublication.latestForDiscovery | 465a0b1e-d9df-4342-b738-86ffcafc4bcf |


